Regen BioPharma Inc Share Price OTC Bulletin Board
Equities
US75886M1027
Biotechnology & Medical Research
Sales 2022 | 2L 1.96Cr | Sales 2023 | 2L 1.96Cr | Capitalization | 63.29L 53Cr |
---|---|---|---|---|---|
Net income 2022 | 20L 17Cr | Net income 2023 | 10L 8.3Cr | EV / Sales 2022 | 144 x |
Net Debt 2022 | 12.23L 10Cr | Net Debt 2023 | 6L 5.27Cr | EV / Sales 2023 | 29.4 x |
P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
6.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.99% |
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 24/12/24 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.39TCr | |
-1.69% | 2.16TCr | |
-10.60% | 1.9TCr | |
-41.25% | 1.7TCr | |
-15.33% | 1.63TCr | |
+5.80% | 1.41TCr | |
+28.03% | 1.2TCr |